Sight Sciences Inc (NAS:SGHT)
$ 4.68 -0.42 (-8.24%) Market Cap: 235.44 Mil Enterprise Value: 172.91 Mil PE Ratio: 0 PB Ratio: 2.51 GF Score: 75/100

Sight Sciences Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 07:35PM GMT
Release Date Price: $3.28 (-49.62%)
Kallum Titchmarsh
Morgan Stanley - Analyst

Perfect. Thank you very much, everyone. Really pleased today to have the team from Sight Sciences here. We got Paul Badawi, CEO; and Ali Bauerlein, CFO. Thank you so much.

Before we get started, we have to read you some fun disclosures here. So for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures.

Paul, obviously probably a bit dizzy today a little bit. Actually, yeah, maybe provide us some high-level overviews of the update you provided to us yesterday.

Paul Badawi
Sight Sciences, Inc. - Founder and CEO

On the LCDs?

Kallum Titchmarsh
Morgan Stanley - Analyst

We'll start on the LCDs, and then we can get over to [the matter] afterwards.

Questions & Answers

Paul Badawi
Sight Sciences, Inc. - Founder and CEO

Sure, yeah. So just quick

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot